Private profits versus public policy: the pharmaceutical industry and the Canadian state
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Toronto ; Buffalo ; London
University of Toronto Press
[2016]
|
| Schlagworte: | |
| Online-Zugang: | FLA01 |
| Beschreibung: | Online resource; title from PDF title page (EBSCO, viewed October 3, 2016) |
| Beschreibung: | 1 online resource |
| ISBN: | 9781442619609 1442619600 9781442619616 1442619619 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045360104 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 181212s2016 |||| o||u| ||||||eng d | ||
| 020 | |a 9781442619609 |9 978-1-4426-1960-9 | ||
| 020 | |a 1442619600 |9 1-4426-1960-0 | ||
| 020 | |a 9781442619616 |9 978-1-4426-1961-6 | ||
| 020 | |a 1442619619 |9 1-4426-1961-9 | ||
| 035 | |a (ZDB-4-EBU)ocn959713789 | ||
| 035 | |a (OCoLC)959713789 | ||
| 035 | |a (DE-599)BVBBV045360104 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 338.4/761510971 |2 23 | |
| 100 | 1 | |a Lexchin, Joel |d 1948- |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Private profits versus public policy |b the pharmaceutical industry and the Canadian state |c Joel Lexchin |
| 264 | 1 | |a Toronto ; Buffalo ; London |b University of Toronto Press |c [2016] | |
| 264 | 4 | |c 2016 | |
| 300 | |a 1 online resource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Online resource; title from PDF title page (EBSCO, viewed October 3, 2016) | ||
| 505 | 8 | |a "The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years."-- | |
| 650 | 7 | |a BUSINESS & ECONOMICS / Industries / General |2 bisacsh | |
| 650 | 7 | |a Pharmaceutical industry / Government policy |2 fast | |
| 650 | 7 | |a Prescription pricing / Government policy |2 fast | |
| 650 | 7 | |a Profit / Government policy |2 fast | |
| 650 | 4 | |a Pharmaceutical industry |x Government policy |z Canada |a Drug development |x Government policy |z Canada |a Prescription pricing |x Government policy |z Canada |a Profit |x Government policy |z Canada | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781442649170 |z 1442649178 |
| 912 | |a ZDB-4-EBU | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030746695 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1362452 |l FLA01 |p ZDB-4-EBU |q FLA_PDA_EBU |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804179192727732224 |
|---|---|
| any_adam_object | |
| author | Lexchin, Joel 1948- |
| author_facet | Lexchin, Joel 1948- |
| author_role | aut |
| author_sort | Lexchin, Joel 1948- |
| author_variant | j l jl |
| building | Verbundindex |
| bvnumber | BV045360104 |
| collection | ZDB-4-EBU |
| contents | "The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years."-- |
| ctrlnum | (ZDB-4-EBU)ocn959713789 (OCoLC)959713789 (DE-599)BVBBV045360104 |
| dewey-full | 338.4/761510971 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/761510971 |
| dewey-search | 338.4/761510971 |
| dewey-sort | 3338.4 9761510971 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02801nmm a2200433zc 4500</leader><controlfield tag="001">BV045360104</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181212s2016 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781442619609</subfield><subfield code="9">978-1-4426-1960-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1442619600</subfield><subfield code="9">1-4426-1960-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781442619616</subfield><subfield code="9">978-1-4426-1961-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1442619619</subfield><subfield code="9">1-4426-1961-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBU)ocn959713789</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)959713789</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045360104</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/761510971</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lexchin, Joel</subfield><subfield code="d">1948-</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Private profits versus public policy</subfield><subfield code="b">the pharmaceutical industry and the Canadian state</subfield><subfield code="c">Joel Lexchin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Toronto ; Buffalo ; London</subfield><subfield code="b">University of Toronto Press</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Online resource; title from PDF title page (EBSCO, viewed October 3, 2016)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">"The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years."--</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Industries / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry / Government policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prescription pricing / Government policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Profit / Government policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Government policy</subfield><subfield code="z">Canada</subfield><subfield code="a">Drug development</subfield><subfield code="x">Government policy</subfield><subfield code="z">Canada</subfield><subfield code="a">Prescription pricing</subfield><subfield code="x">Government policy</subfield><subfield code="z">Canada</subfield><subfield code="a">Profit</subfield><subfield code="x">Government policy</subfield><subfield code="z">Canada</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781442649170</subfield><subfield code="z">1442649178</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBU</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030746695</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1362452</subfield><subfield code="l">FLA01</subfield><subfield code="p">ZDB-4-EBU</subfield><subfield code="q">FLA_PDA_EBU</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV045360104 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:15:58Z |
| institution | BVB |
| isbn | 9781442619609 1442619600 9781442619616 1442619619 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030746695 |
| oclc_num | 959713789 |
| open_access_boolean | |
| physical | 1 online resource |
| psigel | ZDB-4-EBU ZDB-4-EBU FLA_PDA_EBU |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | University of Toronto Press |
| record_format | marc |
| spelling | Lexchin, Joel 1948- Verfasser aut Private profits versus public policy the pharmaceutical industry and the Canadian state Joel Lexchin Toronto ; Buffalo ; London University of Toronto Press [2016] 2016 1 online resource txt rdacontent c rdamedia cr rdacarrier Online resource; title from PDF title page (EBSCO, viewed October 3, 2016) "The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years."-- BUSINESS & ECONOMICS / Industries / General bisacsh Pharmaceutical industry / Government policy fast Prescription pricing / Government policy fast Profit / Government policy fast Pharmaceutical industry Government policy Canada Drug development Government policy Canada Prescription pricing Government policy Canada Profit Government policy Canada Erscheint auch als Druck-Ausgabe 9781442649170 1442649178 |
| spellingShingle | Lexchin, Joel 1948- Private profits versus public policy the pharmaceutical industry and the Canadian state "The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years."-- BUSINESS & ECONOMICS / Industries / General bisacsh Pharmaceutical industry / Government policy fast Prescription pricing / Government policy fast Profit / Government policy fast Pharmaceutical industry Government policy Canada Drug development Government policy Canada Prescription pricing Government policy Canada Profit Government policy Canada |
| title | Private profits versus public policy the pharmaceutical industry and the Canadian state |
| title_auth | Private profits versus public policy the pharmaceutical industry and the Canadian state |
| title_exact_search | Private profits versus public policy the pharmaceutical industry and the Canadian state |
| title_full | Private profits versus public policy the pharmaceutical industry and the Canadian state Joel Lexchin |
| title_fullStr | Private profits versus public policy the pharmaceutical industry and the Canadian state Joel Lexchin |
| title_full_unstemmed | Private profits versus public policy the pharmaceutical industry and the Canadian state Joel Lexchin |
| title_short | Private profits versus public policy |
| title_sort | private profits versus public policy the pharmaceutical industry and the canadian state |
| title_sub | the pharmaceutical industry and the Canadian state |
| topic | BUSINESS & ECONOMICS / Industries / General bisacsh Pharmaceutical industry / Government policy fast Prescription pricing / Government policy fast Profit / Government policy fast Pharmaceutical industry Government policy Canada Drug development Government policy Canada Prescription pricing Government policy Canada Profit Government policy Canada |
| topic_facet | BUSINESS & ECONOMICS / Industries / General Pharmaceutical industry / Government policy Prescription pricing / Government policy Profit / Government policy Pharmaceutical industry Government policy Canada Drug development Government policy Canada Prescription pricing Government policy Canada Profit Government policy Canada |
| work_keys_str_mv | AT lexchinjoel privateprofitsversuspublicpolicythepharmaceuticalindustryandthecanadianstate |